Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$100.29 USD
-8.01 (-7.40%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $99.77 -0.52 (-0.52%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $-1.12 | 3.54% |
Earnings Summary
For their last quarter, Blueprint Medicines (BPMC) reported earnings of -$0.80 per share, beating the Zacks Consensus Estimate of $-1.28 per share. This reflects a positive earnings surprise of 37.50%. Look out for BPMC's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of -$1.12 per share, reflecting a year-over-year increase of 49.09%.
Earnings History
Price & Consensus
Zacks News for BPMC
Earnings Preview: Tango Therapeutics, Inc. (TNGX) Q2 Earnings Expected to Decline
BPMC: What are Zacks experts saying now?
Zacks Private Portfolio Services